Skip to main content
CARMAT logo

CARMAT — Investor Relations & Filings

Ticker · ALCAR ISIN · FR0010907956 LEI · 969500ARXACM0P0KH333 PA Manufacturing
Open in API
Filings indexed 570 across all filing types
Latest filing 2021-01-06 Regulatory Filings
Country FR France
Listing PA ALCAR

About CARMAT

https://www.carmatsa.com/en/

CARMAT is a medical technology company that designs, develops, and markets the Aeson® total artificial heart. This bioprosthetic device provides a therapeutic solution for patients suffering from end-stage biventricular heart failure. Aeson® is designed to replace the native heart, primarily as a bridge to transplantation for eligible patients. A key feature of the device is its self-regulation capability, which uses embedded sensors and biocompatible materials to automatically adapt blood flow based on the patient's physiological needs, thereby mimicking the function of a natural heart.

Recent filings

Filing Released Lang Actions
Informations privilégiées / Autres communiqués
Regulatory Filings Classification · 1% confidence The document is titled "COMMUNIQUE DE PRESSE" (Press Release) and announces the commercial development plan for CARMAT's total artificial heart, including market potential, launch timeline (Q2 2021), and key achievements from 2020 (FDA approval for feasibility study, CE marking). It also announces a videoconference to discuss this plan. This format—a formal announcement detailing strategic updates, financial outlook context, and upcoming operational milestones, issued via press release—is characteristic of an Earnings Release (ER) or a general strategic update. Since it focuses heavily on the commercialization strategy and future plans following the CE mark, rather than just summarizing period-end financial results (which would be ER), and it is not a full, comprehensive report (like 10-K or IR), it fits best as an Earnings Release (ER) which often includes strategic commentary, or potentially a Regulatory Filing (RNS) if it were a mandatory disclosure. Given the content is a strategic business update presented as a press release, ER is the most appropriate fit among the specific options, as these often blend results context with forward-looking strategy. It is not a Report Publication Announcement (RPA) because it contains substantial new information, not just a notice that a report is available.
2021-01-06 French
Inside Information / Other news releases
Regulatory Filings Classification · 1% confidence The document is explicitly titled "PRESS RELEASE" and details the company's commercial and development plan for its total artificial heart, including market size, launch timeline (Q2 2021), clinical plans, and recent achievements (CE Marking, FDA approval for EFS). This format, focusing on key operational and strategic updates released to the public and media, strongly aligns with an Earnings Release (ER), which typically announces key financial/operational highlights following a period or in preparation for a major event. While it discusses strategy, it is not a formal, comprehensive financial report like a 10-K or IR. It is a high-level announcement of recent progress and near-term plans, which fits the definition of an Earnings Release (ER) better than other options. It is not a Call Transcript (CT) or an Investor Presentation (IP), but rather the announcement that precedes or accompanies such events.
2021-01-06 English
Acquisition ou cession des actions de l'émetteur / Information relative au contrat de liquidité
Capital/Financing Update Classification · 1% confidence The document is titled "COMMUNIQUE DE PRESSE" (Press Release) and its subject is "Bilan semestriel du contrat de liquidité contracté avec GILBERT DUPONT" (Semi-annual statement of the liquidity contract entered into with GILBERT DUPONT). It details the number of shares and cash balance held under a liquidity contract as of December 31, 2020, and summarizes the transactions (purchases and sales) during the second half of 2020. This type of regular disclosure regarding share trading activities under a liquidity agreement is a specific type of corporate action disclosure. It is not a full Annual Report (10-K), an Earnings Release (ER), or a comprehensive Interim Report (IR). Since it specifically reports on the status of a liquidity contract, it relates to the company's own share transactions. The closest fit among the provided definitions is 'Transaction in Own Shares' (POS), which covers share repurchase/issuance activities, as liquidity contracts are mechanisms used to manage share price stability or execute buyback programs. Given the context of reporting on the activity of a liquidity provider concerning the company's own shares, POS is the most appropriate classification.
2021-01-05 French
Informations privilégiées / Autres communiqués
Regulatory Filings Classification · 1% confidence The document is explicitly titled "COMMUNIQUE DE PRESSE" (Press Release) and announces a major corporate event: receiving the CE marking for its artificial heart. It provides key highlights, quotes from the CEO regarding future commercial launch plans, and schedules a press conference. This structure—a brief announcement of a significant event or result, rather than the full detailed report itself—aligns best with an Earnings Release (ER) if it were financial results, or more generally, a Regulatory Filing (RNS) or a specific announcement type. Since the core event is a major regulatory/product milestone announcement (CE marking), and it is presented as a press release, it is not a full financial report (10-K, IR) or a presentation (IP). Given the options, this is a general, material corporate announcement. While it is not strictly an earnings release, the format is very similar to an ER, but since it concerns a regulatory/product milestone, it fits well under the general 'Regulatory Filings' (RNS) category as a significant, non-standard filing, or potentially a Capital/Financing Update (CAP) if the CE mark directly leads to immediate commercialization/funding, but RNS is the safest general category for material press releases that don't fit elsewhere. However, looking closely at the definitions, this is a major operational/product announcement. It is not a DVA, DIRS, DIV, or MANG. It is a press release announcing a major operational achievement (CE Mark). This type of announcement, which is material but not a standard periodic financial report, often falls under RNS. Given the context of a major product approval announcement, RNS (Regulatory Filings/General Announcement) is the most appropriate fallback for a material press release that isn't a financial report or management change.
2020-12-23 French
Inside Information / Other news releases
Regulatory Filings Classification · 1% confidence The document is explicitly titled 'PRESS RELEASE' and announces a significant corporate event: receiving the CE marking for its total artificial heart. It includes key financial/operational highlights, quotes from the CEO, details about an upcoming press conference, and standard disclaimers. This format strongly indicates an immediate, high-level announcement to the market, which aligns best with an Earnings Release (ER) if it were quarterly results, but since it is a specific, material, non-financial event announcement (regulatory approval), it fits the general category of a significant corporate update. However, none of the specific codes perfectly capture a 'Regulatory Approval Announcement'. Given the options, this is a material announcement that is not a formal financial report (10-K, IR, MRQ), nor a management change (MANG), nor a dividend (DIV). It is a major operational/regulatory milestone announcement. Since it is a press release detailing a major event, and not a report itself, it is closest to an Earnings Release (ER) in structure (a press release format for key news) or potentially a Regulatory Filing (RNS) as a catch-all for material news. Given the content is a major operational/product milestone announcement, and not a financial result, it is best classified as a general Regulatory Filing (RNS) or potentially an Earnings Release (ER) if we interpret 'ER' broadly as 'Key Event Release'. Since it is a press release announcing a major milestone (CE marking), and not a financial result, RNS (Regulatory Filings/General Announcement) is the most appropriate fallback for material, non-standard announcements. However, if we consider the structure, it is a press release announcing a major event, which often gets grouped with ERs. Let's re-evaluate the definitions. It is not a financial report, not a management change, not a capital event. It is a regulatory milestone achievement. RNS is the best fit for general regulatory announcements that aren't standard forms.
2020-12-23 English
Total du nombre de droits de vote et du capital / Information relative au nombre total de droits de vote et d'actions composant le capital
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is a formal declaration dated December 16, 2020, issued by a French company (Société anonyme) regarding the total number of voting rights and shares composing its capital, referencing Article 223-16 of the General Regulation of the Autorité des marchés financiers (AMF). This type of mandatory disclosure, detailing the share capital structure and voting rights as of a specific date (30.11.2020), is a specific regulatory filing. It is not an Annual Report (10-K), an Earnings Release (ER), or a Dividend Notice (DIV). It most closely aligns with a general regulatory filing or a specific notification about capital structure changes, but since it is a mandatory disclosure of voting rights count, it fits best under the general 'Regulatory Filings' (RNS) category as a specific, non-core financial report type, or potentially a 'Share Issue/Capital Change' (SHA) if the focus was on issuance, but here the focus is on the total count of rights. Given the options, RNS serves as the best general regulatory filing bucket for mandatory AMF disclosures that aren't explicitly covered by other codes like 10-K or ER. However, since it explicitly details the capital structure and voting rights, it is a very specific type of regulatory update. Given the provided definitions, RNS is the most appropriate fallback for specific regulatory updates not listed elsewhere. The document length is short, but it is the report itself, not an announcement of a report.
2020-12-16 French

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.